Skip to main content

Advertisement

SpringerLink
Log in

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

  • Published:
International Journal of Mental Health and Addiction Aims and scope Submit manuscript

Abstract

Emergence of synthetic cannabinoids (SCBs) in herbal smoking mixtures is a public health concern. New SCB’s such as 5f-AKB48 and 5F-PB-22 have been detected in French seizures and in sudden death post mortems in the US. The aim was to describe development of dependence on herbal smoking mixtures containing the SCB’s, 5f-AKB48 and 5F-PB-22 and subsequent withdrawal syndromes. Dependent users of herbal smoking mixtures known to contain the SCB’s 5f-AKB48 and 5F-PB-22 with an average Severity of Dependence Score (SDS) of 13 were interviewed using a structured guide (three males/three females). Narratives were analysed using the Empirical Phenomenological Psychological (EPP) five step method. Six themes with 68 categories emerged from the analysis. Themes are illustrated as 1) Networks and Product Availability; 2) Drivers and Motives for Use; 3) Effect and Pathways toward Dependence; 4) Poly Substance Use and Comparisons to Natural Cannabis; 5) Dependence and Withdrawal and 6) Self-detoxification Attempts. Two higher levels of abstraction above these theme-levels emerged from the data, with sole use of herbal smoking mixtures containing 5f-AKB48 and 5F-PB-22 centering on the interplay between intense cravings, compulsive all-consuming seeking, use and re-dose behaviours, and fear of the psychiatric and self-harms caused when in withdrawal. This is the first study describing dependence and withdrawal experiences in users dependent on 5f-AKB48 and 5F-PB-22. Given the potential for adverse psychiatric and physical consequences of dependent use, further development of specific clinical responses and clinical research around toxicity and withdrawal severity are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arfken, C. L., Owens, D., Madeja, C., & DeAngelis, C. (2014). Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathiones. Journal of Psychoactive Drugs, 46, 362–368. doi:10.1080/02791072.2014.959214.

    Article  PubMed  Google Scholar 

  • Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009). ‘spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832–837. doi:10.1002/jms. 1558.

    Article  PubMed  Google Scholar 

  • Banerji S, Deutsch CM, Bronstein AC (2010) SPICE Ain’t So Nice. http://rmpdc.org/Portals/23/Spice Poster Final 2010.pdf Accessed May 22nd 2015.

  • Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32, 141–146. doi:10.1111/j.1465-3362.2012.00519.x.

    Article  PubMed  Google Scholar 

  • Baumann, M. H., Solis Jr., E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014). Baths salts, spice, and related designer drugs: the science behind the headlines. The Journal of Neuroscience, 34, 15150–15158. doi:10.1523/JNEUROSCI.3223-14.2014.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bebarta, V. S., Ramirez, S., & Varney, S. V. (2012). Spice: A new “legal” herbal mixture abused by young active duty military personnel. Substance Abuse, 33, 191–194. doi:10.1080/08897077.2011.637610.

    Article  PubMed  Google Scholar 

  • Behonick, G., Shanks, K. G., Firchau, D. J., Mathur, G., Lynch, C. F., Nashelsky, M., Jaskierny, D. J., & Meroueh, C. (2014). Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5FPB22. Journal of Analytical Toxicology, 38, 559–562. doi:10.1093/jat/bku048.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berry-Caban, C. S., Ee, J., Ingram, V., Berry, C. E., & Kim, E. H. (2013). Synthetic cannabinoid overdose in a 20-year-old Male US soldier. Substance Abuse, 34, 70–72. doi:10.1080/08897077.2012.677754.

    Article  PubMed  Google Scholar 

  • Brents, L. K., & Prather, P. L. (2014). The K2/spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Reviews, 46, 72–85. doi:10.3109/03602532.2013.839700.

    Article  CAS  PubMed  Google Scholar 

  • Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., & Prather, P. L. (2011). Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PloS One, 6, e21917. doi:10.1371/journal.pone.0021917.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brents, L. K., Gallus-Zawada, A., Radominska-Pandya, A., Vasilievik, T., Prisinzano, T. E., Fantegrossi, W. E., Moran, J. H., & Prather, P. L. (2012). Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochemical Pharmacology, 83, 952–961. doi:10.1016/j.bcp.2012.01.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. The International Journal on Drug Policy, 24, 231–237. doi:10.1016/j.drugpo.2012.12.002.

    Article  PubMed  Google Scholar 

  • Bryner J (2010) Fake weed, real drug: K2 causing hallucinations in teens. In: Live Science. Available via DIALOG. http://www.livescience.com/health/fake-marijuana-k2-hallucinations-100303.html . Accessed March 16th 2010.

  • Budney, A. J., & Stanger, C. (2012). Cannabis use and misuse. In J. M. Rey (Ed.), IACAPAP e-textbook of child and adolescent mental health (p. G2). Geneva: International Association for Child and Adolescent Psychiatry and Allied Profession.

    Google Scholar 

  • Castellanos, D., Singh, S., Thornton, G., Avila, M., & Moreno, A. (2011). Synthetic cannabinoid use: A case series of adolescents. The Journal of Adolescent Health, 49, 347–349. doi:10.1016/j.jadohealth.2011.08.002.

    Article  PubMed  Google Scholar 

  • Caviness, C. M., Tzilos, G., Anderson, B. J., & Stein, M. D. (2015). Synthetic cannabinoids: use and predictors in a community sample of young adults. Substance Abuse, 36, 368–373. doi:10.1080/08897077.2014.9591.

    Article  PubMed  Google Scholar 

  • Chung, T., Martin, C. S., Cornelius, J. R., & Clark, D. B. (2008). Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. Addiction, 103, 787–799. doi:10.1111/j.1360-0443.2008.02158.x.

    Article  PubMed  PubMed Central  Google Scholar 

  • Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Sanci, L., & Patton, G. C. (2002). Cannabis dependence in young adults: an Australian population study. Addiction, 97, 187–194.

    Article  PubMed  Google Scholar 

  • Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., Simmons, M. S., & Gorelick, D. A. (2006). Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American Journal on Addictions, 15, 8–14.

    Article  PubMed  Google Scholar 

  • Cornelius, J. R., Chung, T., Martin, C., Wood, D. S., & Clark, D. B. (2008). Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addictive Behaviors, 33, 1500–1505. doi:10.1016/j.addbeh.2008.02.001.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dargan, P. I., Hudson, S., Ramsey, J., & Wood, D. M. (2011). The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in ‘spice’. The International Journal on Drug Policy, 22, 274–277. doi:10.1016/j.drugpo.2011.02.006.

    Article  PubMed  Google Scholar 

  • Deluca, P., Schifano, F., Davey, Z., Corazza, O., di Furia, L., Farre, M., Flesland, L., Mannonen, M., Majava, A., Valentina, M., Pagani, S., Peltoniemi, T., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., Pezzolesi, C., & van der Kreeft, P. (2009). Spice report Psychonaut Web Mapping Research Project. King’s College London: The Psychonaut Web Mapping Research Group.

    Google Scholar 

  • Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwarter, V. (2011). Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163–171. doi:10.1002/jms.1877.

    Article  CAS  PubMed  Google Scholar 

  • Egan, K. L., Suerken, C. K., Reboussin, B. A., Spangler, J., Wagoner, K. G., Sutfin, E. L., Debinski, B., & Wolfson, M. (2015). K2 and spice use among a cohort of college students in southeast region of the USA. The Am J Drug Alcohol Abuse, 41, 317–322. doi:10.3109/00952990.2015.1043438.

    Article  PubMed  Google Scholar 

  • European Monitoring Centre for Drugs and Drug Addiction – EMCDDA (2009) Thematic paper - Understanding the ‘spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg. Available via DIALOG. http://www.emcdda.europa.eu/publications/thematic-papers/spice. Accessed 28th July 2013.

  • Ernst, L., Schiebel, H. M., Theuring, C., Lindigkeit, R., & Beuerle, T. (2011). Identification and characterization of JWH-122 used as new ingredient in “spice-like” herbal incenses. Forensic Science International, 208, e31–e35. doi:10.1016/j.forsciint.2011.03.020.

    Article  CAS  PubMed  Google Scholar 

  • Every-Palmer, S. (2010). Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105, 1859–1860. doi:10.1111/j.1360-0443.2010.03119.x.

    Article  PubMed  Google Scholar 

  • Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug and Alcohol Dependence, 117, 152–157. doi:10.1016/j.drugalcdep.2011.01.012.

    Article  CAS  PubMed  Google Scholar 

  • Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45–54. doi:10.1016/j.lfs.2013.09.017.

    Article  CAS  PubMed  Google Scholar 

  • Fattore, L., & Fratta, W. (2011). Beyond THC: the new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience, 5, 60. doi:10.3389/fnbeh.2011.00060.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Forrester, M. B., Kleinschmidt, K., Schwarz, E., & Young, A. (2011). Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases, 30, 351–358. doi:10.1080/10550887.2011.609807.

    Article  PubMed  Google Scholar 

  • Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, K. S. (2007). Addiction, 10, 920–930.

    Article  Google Scholar 

  • Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.

    Article  CAS  PubMed  Google Scholar 

  • Griffiths, P., Sedefov, R., Gallegos, A., & Lopez, D. (2010). How globalization and market innovation challenge how we think about and respond to drug use: ‘spice’ a case study. Addiction, 105, 951–953. doi:10.1111/j.1360-0443.2009.02874.x.

    Article  PubMed  Google Scholar 

  • Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., & Rozhanets, V. (2011a). Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 2519–2526. doi:10.1016/j.jchromb.2011.07.004.

    Article  CAS  PubMed  Google Scholar 

  • Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M., Nosyrev, A., Vedenin, A., Izotov, B., Zabirova, I., & Rozhanets, V. (2011b). Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 1126–1136. doi:10.1016/j.jchromb.2011.03.034.

    Article  CAS  PubMed  Google Scholar 

  • Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21, 320–326. doi:10.1111/j.1521-0391.2012.00240.x.

    Article  PubMed  Google Scholar 

  • Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2014). A survey of synthetic cannabinoid consumption by current cannabis users. Substance Abuse, 35, 184–189. doi:10.1080/08897077.2013.846288.

    Article  PubMed  PubMed Central  Google Scholar 

  • Helander, A., Beck, O., Hägerkvist, R., & Hulthén, P. (2013). Identification of novel psychoactive drug use in Sweden based on laboratory analysis: initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation, 73, 400–406. doi:10.3109/00365513.2013.793817.

    Article  CAS  PubMed  Google Scholar 

  • Hermanns-Clausen, M., Kneisel, S., Szabo, B., & Auwarter, V. (2013). Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534–544. doi:10.1111/j.1360-0443.2012.04078.x.

    Article  PubMed  Google Scholar 

  • Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the internet. Substance Use & Misuse, 45, 330–340. doi:10.3109/10826080903443628.

    Article  Google Scholar 

  • Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34, 252–260.

    Article  CAS  PubMed  Google Scholar 

  • Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: a case series. The American Journal of Psychiatry, 168, 1119. doi:10.1176/appi.ajp.2011.11010176.

    Article  PubMed  Google Scholar 

  • Husserl, E. (1970). Logical investigation. New York: Humanities Press.

    Google Scholar 

  • Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & JE, S. (2015). Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Institute For Social Research. Ann Arbor, MI: The University of Michigan.

    Google Scholar 

  • Karlsson, G. (1995). Psychological qualitative research from a phenomenological perspective. Stockholm, Sweden: Almqvist & Wiksell International.

    Google Scholar 

  • Kavanagh P, Spiers P, O’Brien J, McNamara S, Angelov D, Mullan D, Talbot B, Ryder S (2010) Head shop ‘legal highs’ active constituents identification chart (July/August 2010, ‘714’ – ‘823’). Department of Pharmacology and Therapeutics, TCD, Dublin. Available via http://www.drugs.ie/pdfs/2010/head_shop_ID_poster_may_post_ban.pdf. Accessed 20th July 2015.

  • Kikura-Hanajiri, R., Uchiyama, N., & Goda, Y. (2011). Survey of current trends in the abuse of psychotropic substances and plants in Japan. Leg Med (Tokyo), 13, 109–115. doi:10.1016/j.legalmed.2011.02.003.

    Article  Google Scholar 

  • Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE)–a phenomenological study of experiences induced by a “legal high” from the internet. Journal of Psychoactive Drugs, 45, 276–286.

    Article  PubMed  PubMed Central  Google Scholar 

  • Levasseur, J. J. (2003). The problem of bracketing in phenomenology. Qualitative Health Research, 13, 408–420. doi:10.1177/1049732302250337.

    Article  PubMed  Google Scholar 

  • Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.

    Google Scholar 

  • Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009). Spice: A never ending story? Forensic Science International, 191, 58–63. doi:10.1016/j.forsciint.2009.06.008.

    Article  CAS  PubMed  Google Scholar 

  • McElrath, K., & Van Hout, M. C. (2011). A preference for mephedrone: Drug Markets, drugs of choice and the emerging ‘legal high’ scene. Journal of Drug Issues, 41, 487–507.

    Article  Google Scholar 

  • Meshack A, Peters RJ.Jr, Mi-Ting L, Hill M, Abughosh S, Essien EJ, Savage C (2013) The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies 28:109–113.

  • Müller, H., Huttner, H. B., Kohrmann, M., Wielopolski, J. E., Kornhuber, J., & Sperling, W. (2010a). Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry, 43, 152–153. doi:10.1055/s-0029-1243252.

    Article  PubMed  Google Scholar 

  • Müller, H., Sperling, W., Kohrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010b). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309–310. doi:10.1016/j.schres.2009.12.001.

    Article  PubMed  Google Scholar 

  • Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says: research suggests marijuana may be a ‘component cause’ of psychosis. Current Psychology, 10, 9.

    Google Scholar 

  • Rominger, A., Cumming, P., Xiong, G., Koller, G., Forster, S., Zwergal, A., Karamatskos, E., Bartenstein, P., La Fougere, C., & Pogarell, O. (2013). Effects of acute detoxification of the herbal blend ‘spice gold’ on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology, 23, 1606–1610. doi:10.1016/j.euroneuro.2013.01.009.

    Article  CAS  PubMed  Google Scholar 

  • Roussel, O., Carlin, M. G., Bouvot, X., & Tensorer, L. (2015). The emergence of synthetic cannabinoids in Mayotte. Toxicologie Analytique et Clinique, 27, 18–22. doi:10.1016/j.toxac.2014.12.002.

    Article  Google Scholar 

  • Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., Farre, M., Flores, I., Rossi, M., Eastwood, D., Guionnet, C., Rawaf, S., Agosti, L., Di Furia, L., Brigada, R., Majava, A., Siemann, H., Leoni, M., Tomasin, A., Rovetto, F., & Ghodse, A. H. (2006). Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 640–646.

    Article  Google Scholar 

  • Schifano, F., Corazza, O., Deluca, P., Davey, Z., Lucia, D. F., Farre, M., Flesland, L., Mannonen, M., Pagani, S., Peltoniemi, T., Pezzolesi, C., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., & Van Der Kreeft, P. (2009). Psychoactive drug mystical incense? overview of the online available information on spice products. Int J Cult Ment Health, 2, 137–144. doi:10.1080/17542860903350888.

    Article  Google Scholar 

  • Schifano, F., Ricciardi, A., Corazza, O., Deluca, P., Davey, Z., & Rafanelli, C. (2010). New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project. Rivista di Psichiatria, 45, 88–93.

    PubMed  Google Scholar 

  • Schneir, A. B., Cullen, J., & Ly, B. T. (2011). “spice” girls: synthetic cannabinoid intoxication. The Journal of Emergency Medicine, 40, 296–269. doi:10.1016/j.jemermed.2010.10.014.

    Article  PubMed  Google Scholar 

  • Seely, K. A., Prather, P. L., James, L. P., & Moran, J. H. (2011). Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Molecular Interventions, 11, 36–51. doi:10.1124/mi.11.1.6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seely, K. A., Lapoint, J., Moran, J. H., & Frattore, L. (2012). Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 234–243. doi:10.1016/j.pnpbp.2012.04.017.

    Article  CAS  Google Scholar 

  • Simmons, J. R., Skinner, C. G., Williams, J., Kang, C. S., Schwartz, M. D., & Wills, B. K. (2011a). Intoxication from smoking “spice”. Annals of Emergency Medicine, 57, 187–188. doi:10.1016/j.annemergmed.2010.08.039.

    Article  PubMed  Google Scholar 

  • Simmons, J., Cookman, L., Kang, C., & Skinner, C. (2011b). Three cases of “spice” exposure. Clinical Toxicology (Philadelphia, Pa.), 49, 431–433. doi:10.3109/15563650.2011.584316.

    Article  CAS  Google Scholar 

  • Sobolevsky, T., Prasolov, I., & Rodchenkov, G. (2010). Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200, 141–147. doi:10.1016/j.forsciint.2010.04.003.

    Article  CAS  PubMed  Google Scholar 

  • Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31, 207–220.

    Article  Google Scholar 

  • Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: synthetic cannabinoids. Psychopharmacology, 228, 525–540. doi:10.1007/s00213-013-3188-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Arch Psychiatry, 22, 31–33.

    CAS  PubMed  Google Scholar 

  • Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske Lægeforening, 132, 2285–2288. doi:10.4045/tidsskr.12.0471.

    Article  PubMed  Google Scholar 

  • Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010). Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International, 198, 31–38. doi:10.1016/j.forsciint.2010.01.004.

    Article  CAS  PubMed  Google Scholar 

  • Van der Veer, N., & Fiday, J. (2011). Persistent psychosis following the use of spice. Schizophrenia Research, 130, 285–286. doi:10.1016/j.schres.2011.04.022.

    Article  PubMed  Google Scholar 

  • Van Hout, M. C., & Bingham, T. (2012). A costly turn On: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. The International Journal on Drug Policy, 23, 188–197. doi:10.1016/j.drugpo.2012.01.008.

    Article  PubMed  Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2011a). Plantfood for thought: A qualitative study of mephedrone use in Ireland. Drugs: Educ Prev Polic, 18, 371–381. doi:10.3109/09687637.2010.537713.

    Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2011b). Bump and grind: An exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drug Alcohol Today, 11, 93–104.

    Article  Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2011c). Heads held high: An exploratory study of legal highs in pre legislation Ireland. Journal of Ethnicity in Substance Abuse, 10, 256–272. doi:10.1080/15332640.2011.600210.

    Article  PubMed  Google Scholar 

  • Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: A post legislative study on mephedrone use in Ireland. Drugs: Educ Prev Polic, 19, 156–162.

    Google Scholar 

  • Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012). A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence, 120, 238–241. doi:10.1016/j.drugalcdep.2011.07.011.

    Article  CAS  PubMed  Google Scholar 

  • Vardakou, I., Pistos, C., & Spiliopoulou, C. H. (2010). Spice drugs as a new trend: mode of action, identification and legislation. Toxicology Letters, 197, 157–162. doi:10.1016/j.toxlet.2010.06.002.

    Article  CAS  PubMed  Google Scholar 

  • Vearrier, D., & Osterhoudt, K. C. (2010). A teenager with agitation: higher than she should have climbed. Pediatric Emergency Care, 26, 462–465. doi:10.1097/PEC.0b013e3181e4f416.

    Article  PubMed  Google Scholar 

  • Wallendorf, M., & Belk, R. W. (1989). Assessing trustworthiness in naturalistic consumer research. In E. C. Hirschman (Ed.), Interpretive consumer research (pp. 69–84). Provo, UT: Association for Consumer Research.

    Google Scholar 

  • Westphal, F., Junge, T., Sonnichsen, F., Rosner, P., & Schaper, J. (2010). Ein neuer wirkstoff in SPICE-artigen Kräutermischungen: charakterisierung von JWH-250, seinen methyl-und trimethylsilylderivaten [A new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77, 46–58.

    Google Scholar 

  • Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131, 106–111. doi:10.1016/j.drugalcdep.2012.12.011.

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009). Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Deutsches Ärzteblatt International, 106, 464–467. doi:10.3238/arztebl.2009.0464.

    PubMed  PubMed Central  Google Scholar 

  • Zuba, D., Byrska, B., & Maciow, M. (2011). Comparison of “herbal highs” composition. Analytical and Bioanalytical Chemistry, 400, 119–126. doi:10.1007/s00216-011-4743-7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Health Service Executive, and Teach na nDaoine, Ireland. The opinions expressed in this article are of the researchers and are not necessarily those of the funders.

Author information

Authors and Affiliations

  1. School of Health Sciences, Waterford Institute of Technology, Waterford, Ireland

    Marie Claire Van Hout & Evelyn Hearne

Authors
  1. Marie Claire Van Hout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evelyn Hearne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie Claire Van Hout.

Ethics declarations

Conflict of Interest

Authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Hout, M.C., Hearne, E. User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. Int J Ment Health Addiction 15, 565–579 (2017). https://doi.org/10.1007/s11469-016-9650-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11469-016-9650-x

Keywords

Search

Navigation